NCT04483154

Brief Summary

The principal objective of the study is to determine if patient-empowered, real-time and home- based patient monitoring of vital parameters can lead to:

  • Reduction in admission rates and improved clinical management of chronically ill patients
  • Reduction in use of medications
  • Reported quality of life A minimum of 100 patients will be recruited, monitored and observed over 6 months from home with the Coala Heart Monitor. The study population will be representative of rural, high-risk, Medicare (65+ of age) subjects with chronic conditions and will be recruited by the Perry Community Hospital in Linden, TN.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

July 24, 2020

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

July 20, 2020

Last Update Submit

July 23, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Reducing admission rates

    6 months

  • Reduction in use of medications

    6 months

  • Increased quality of life

    As measured by Rand-36

    6 months

  • Improved clinical management

    6 months

Secondary Outcomes (2)

  • Show the value of using Coala Heart Monitor in rural care - patients

    6 months

  • Show the value of using Coala Heart Monitor in rural care - providers

    6 months

Interventions

The Coala Heart Monitor (Coala Life AB, Sweden) is a CE and FDA-cleared device for real-time, remote monitoring of 2-lead ECG as well as heart and lung sounds. The Coala Heart Monitor automatically detects for 9 of the most common arrhythmias and has an integrated stethoscope for remote auscultation. It is paired wirelessly with the patient's smartphone and results are provided instantly both to patient and to connected provider in the cloud-based Coala Care portal.

Eligibility Criteria

Age65 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Rural population with chronic illnesses and high admission rates

You may qualify if:

  • History of frequent admissions, defined as minimum of 2 during the last 6 months
  • ICD diagnosis for COPD and/or hypertension and/or diabetes and/or cardiovascular diseases
  • Patient has Smartphone or Tablet, as well as Internet connection in their homes (or 3G/4G/5G connection)

You may not qualify if:

  • Subjects with Pacemaker, ICD or Implanted Loop Recorder
  • Subjects with no experience in using Smartphones and Apps
  • Vulnerable Subjects (prisoners, elderly with decisional incapacity)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Perry Community Hospital

Linden, Tennessee, 37096, United States

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveArrhythmias, CardiacHeart MurmursChronic Disease

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular DiseasesSigns and Symptoms

Study Officials

  • David Huneycutt, MD

    Perry Community Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valentina Lepsky-Perla, MSc

CONTACT

Martha Wilsdorf, RN

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 23, 2020

Study Start

August 1, 2020

Primary Completion

February 1, 2021

Study Completion

February 1, 2021

Last Updated

July 24, 2020

Record last verified: 2020-07

Locations